Clinical Research Directory
Browse clinical research sites, groups, and studies.
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
Sponsor: University Hospital Augsburg
Summary
A prospective observational trial of patients with metastatic cancer of various entities which aims at both clarifying the significance of liquid biopsy and establishing a foundation for translational research.
Official title: Augsburg Longitudinal Plasma Study (ALPS) to Study Liquid Biopsy (LBx) as a Tool for Diagnostic Support, Assessment of Disease Progression, and Identification of Mutations During Disease Course in Patients With Solid Neoplasms Receiving Palliative Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2021-03-29
Completion Date
2030-03
Last Updated
2026-07-30
Healthy Volunteers
No
Locations (1)
University Hospital Augsburg
Augsburg, Bavaria, Germany